{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T09:34:11Z","timestamp":1769247251630,"version":"3.49.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>The aim of this study was to determine the natural course of vitreomacular traction (VMT) in patients with diabetic retinopathy and to evaluate the factors associated with VMT relief.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Seventy-four eyes of 65 patients with VMT accompanying diabetic retinopathy were evaluated retrospectively. The presence of intravitreal injection and the presence of panretinal photocoagulation were obtained from the medical records of the patients. Spontaneous release of VMT, the horizontal length of vitreomacular traction, the presence of hyperreflective retinal spots, the presence of the epiretinal membrane, and the grade of VMT were evaluated from the spectral-domain optical coherence tomography images. Factors associated with the spontaneous release of VMT were evaluated by logistic regression analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Spontaneous release was observed in 28 eyes (37.8%). The horizontal length of VMT was lower in the release of the VMT group compared with the persistent VMT group (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.03). The persistent VMT group had a higher rate of hyperreflective retinal spots and epiretinal membrane compared with the release of the VMT group (respectively; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.003 and <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.031). No statistically significant difference was observed between the release of VMT and persistent VMT groups in terms of intravitreal injection and panretinal photocoagulation treatment (respectively; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.938 and <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.36). The absence of hyperreflective retinal spots was the most important prognostic factor for the spontaneous release of VMT (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.029).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Spontaneous release of VMT observed higher rates of patients without hyperreflective retinal spots, epiretinal membrane, and patients with lower horizontal length of VMT.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003093","type":"journal-article","created":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T08:00:30Z","timestamp":1609142430000},"page":"1668-1674","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["NATURAL COURSE OF VITREOMACULAR TRACTION IN EYES WITH DIABETIC RETINOPATHY AND FACTORS ASSOCIATED WITH SPONTANEOUS RELEASE"],"prefix":"10.1097","volume":"41","author":[{"given":"R\u00fcveyde","family":"Garip","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u00e7a K\u00fcpeli","family":"\u00c7\u0131nar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulkadir Can","family":"\u00c7\u0131nar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vuslat","family":"G\u00fcrl\u00fc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-9394(00)00872-2","article-title":"Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction","volume":"131","author":"Kaiser","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0002-9394(14)73813-9","article-title":"Course of vitreomacular traction syndrome","volume":"119","author":"Hikichi","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ajo.2007.07.012","article-title":"Optical coherence tomography findings in persistent diabetic macular edema: the vitreomacular interface","volume":"144","author":"Ghazi","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000098501","article-title":"Diffuse diabetic macular edema: pathology and implications for surgery","volume":"39","author":"Gandorfer","year":"2007","journal-title":"Dev Ophthalmol"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/ICU.0000000000000149","article-title":"Clinical management of vitreomacular traction","volume":"26","author":"Khan","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.ophtha.2013.07.042","article-title":"The International Vitreomacular Traction Study group classification of vitreomacular adhesion, traction, and macular hole","volume":"120","author":"Duker","year":"2013","journal-title":"Ophthalmology"},{"key":"R7-20250607","first-page":"28","article-title":"Diabetic macular edema: current understanding, pharmacologic treatment options, and developing therapies","volume":"7","author":"Miller","year":"2018","journal-title":"Asia Pacific J Ophthalmol"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0161-6420(88)33004-6","article-title":"The role of the vitreous in diabetic macular edema","volume":"95","author":"Nasrallah","year":"1998","journal-title":"Ophthalmology"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1177\/112067210401400511","article-title":"Spontaneous resolution of vitreomacular traction associated with diabetic macular edema","volume":"14","author":"Lecleire-Collet","year":"2004","journal-title":"Eur J Ophthalmol"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000360219","article-title":"Spontaneous resolution of vitreomacular traction in two patients with diabetic macular edema","volume":"5","author":"Almeida","year":"2014","journal-title":"Case Rep Ophthalmol"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.2147\/OPTH.S146019","article-title":"Vitreoretinal interface abnormalities in diabetic macular edema and effectiveness of anti-VEGF therapy: an optical coherence tomography study","volume":"11","author":"Kulikov","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00417-018-4009-6","article-title":"Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy","volume":"256","author":"Mikhail","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1167\/iovs.17-21769","article-title":"Local and systemic inflammatory biomarkers of diabetic retinopathy: an integrative approach","volume":"58","author":"Vujosevic","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/IAE.0b013e3182a15f8b","article-title":"Clinical course of vitreomacular adhesion managed by initial observation","volume":"34","author":"John","year":"2014","journal-title":"Retina"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/IAE.0b013e31828991d6","article-title":"Vitreous attachment in age-related macular degeneration, diabetic macular edema, and retinal vein occlusion: a systematic review and metaanalysis","volume":"33","author":"Jackson","year":"2013","journal-title":"Retina"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/IAE.0000000000000346","article-title":"Factors associated with spontaneous release of vitreomacular traction","volume":"35","author":"Almeida","year":"2015","journal-title":"Retina"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/112067210801800223","article-title":"Spontaneous resolution of vitreomacular traction following ranibizumab (lucentis) injection","volume":"18","author":"Rouvas","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ophtha.2015.09.032","article-title":"Effect of vitreomacular adhesion on treatment outcomes in the ranibizumab for edema of the macula in diabetes (READ-3) study","volume":"123","author":"Sadiq","year":"2016","journal-title":"Ophthalmology"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/eye.2016.317","article-title":"The incidence and risk factors for the development of vitreomacular interface abnormality in diabetic macular edema treated with intravitreal injection of anti-VEGF","volume":"31","author":"Chang","year":"2017","journal-title":"Eye (Lond)"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tjo.2012.05.001","article-title":"Development of vitreomacular interface abnormality in patients with diabetic macular edema","volume":"2","author":"Chang","year":"2012","journal-title":"Taiwan J Ophthalmol"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00417-008-0914-4","article-title":"Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy","volume":"246","author":"Moradian","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1167\/iovs.17-22725","article-title":"Association between hyperreflective dots on spectral-domain optical coherence tomography in macular edema and response to treatment","volume":"58","author":"Hwang","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R23-20250607","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/392983","article-title":"The vitreomacular interface in diabetic retinopathy","volume":"2015","author":"Agarwal","year":"2015","journal-title":"J Ophthalmol"},{"key":"R24-20250607","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0161-6420(96)30697-0","article-title":"Recognition of vitreoschisis in proliferative diabetic retinopathy. A useful landmark in vitrectomy for diabetic traction retinal detachment","volume":"103","author":"Schwatz","year":"1996","journal-title":"Ophthalmology"},{"key":"R25-20250607","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ajo.2004.11.035","article-title":"Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction","volume":"139","author":"Gandorfer","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00006982-200001000-00012","article-title":"Electron immunocytochemical analysis of posterior hyaloid associated with diabetic macular edema","volume":"20","author":"Jumper","year":"2000","journal-title":"Retina"},{"key":"R27-20250607","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00417-009-1147-x","article-title":"Panretinal photocoagulation induces pro-inflammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy","volume":"247","author":"Shimura","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R28-20250607","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/IAE.0b013e3181eef08c","article-title":"Long-term evaluation of vitreomacular traction disorder in spectral-domain optical coherence tomography","volume":"31","author":"Odrobina","year":"2011","journal-title":"Retina"},{"key":"R29-20250607","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ophtha.2017.10.035","article-title":"A study of the natural history of vitreomacular traction syndrome by OCT","volume":"125","author":"Errera","year":"2018","journal-title":"Ophthalmology"},{"key":"R30-20250607","first-page":"2515841419869511","article-title":"Enzymatic vitreolysis for the treatment of tractional diabetic macular edema","volume":"11","author":"Pessoa","year":"2019","journal-title":"Ther Adv Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003093","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:03:42Z","timestamp":1749319422000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003093","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]}}}